All the Therapeutic System Drugs
Insulins and Analogues. Insulin Human 100 U/ml. VIALS: 10 ml x 100 IU/ml.
PENFILL: 5 x 3 ml x 100 IU/ml for use
with NovoPen 3 inject. device tog. with
NovoFine needles; 5 x 1.5 ml x 100 IU/ml
for use with NovoPen II inject. device
tog. with NovoFine needles.
Diabetes mellitus, stabilisation of diabetes
in cases where several daily doses are
requested. Precoma and coma
diabeticum.
Insulins and Analogues. Insulin Glulisine 100 U/ml. CARTRIDGES (sol. for inject.) 5 x 3 ml.
VIAL (sol. for inject): 1 x 10 ml.
PRE-FILLED PENS (SoloStar): 5 x 3 ml.
Adjust individ. To be given shortly
(0-15 mins.) bef./soon aft. meals. To be
used in regimens that incl. intermed.
or long act. insulin or basal insulin
analog. Can be used with oral
hypoglycem. agents. S.C. inject. or
contin. infus. into abdom. wall.
Rotate inject. and infus. sites.
Tmt. adult, adolesc., child. over 6 yrs. with
diabetes mellitus where tmt. with insulin
reqd.
C/I: Hypersens. to insulin glulisine or
Excips, hypoglic.
Long Acting Insulin. Insulin Glargine 100 U/ml. Cartridge (sol. for inj.): 5×3 ml
Pre-filled Pen (sol.for inj.): 5 ×3 ml
Should be admin. once dly. at any time but at the same time each day.
Dose regimen should be individ. adjust. In pts. with type 2 diabetes mell., the drug can also be given together with orally active antidiabetic med. products.
The potency of this med. product is stated in units. These units are exclusive to insulin glargine and are not the same as IU or the units used to express the potency of other insulin analog. See lit.
Tmt. of adult pts. 18 yrs. and over with type 1 or type 2 diabetes mell. who require basal (long act.) insulin for the control of hyperglycaem.
C/I: Hypersens.
Fast-Acting Human Insulin Analog. Insulin Lispro 100 IU/ml. VIALS: 1x 10 ml x 100 IU/ml.
CARTRIDGE: 5 x 3 ml x 100 IU/ml.
Rapid acting insulin, onset: 15-30
mins., peak: 0.5-2.5 hrs., durat.: 2-4 hrs.
Diabetes mellitus adults, child.
C/I: Hypersens., hypoglycem.
